Chronic Myeloid Leukemia

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Hematology
Cover of the book Chronic Myeloid Leukemia by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319331980
Publisher: Springer International Publishing Publication: August 17, 2016
Imprint: Springer Language: English
Author:
ISBN: 9783319331980
Publisher: Springer International Publishing
Publication: August 17, 2016
Imprint: Springer
Language: English

This book provides state-of-the-art reviews of key issues and recent developments relating to chronic myeloid leukemia (CML), acquainting the reader with advances in research, treatment, and promotion of public health. Among the management topics addressed are the choices, advantages, and pitfalls of first-, second-, and third-line treatments; the European LeukemiaNet recommendations; management of adverse effects of tyrosine kinase inhibitors (TKI); management of CML blast crisis; management of pregnancy in the context of CML; the role of hematopoietic cell transplantation; the current experience with TKI discontinuation; and the value of interferon α in improving the outcome of TKI treatment. Various aspects of relevance to treatment outcome are discussed, including prognostic scores, molecular monitoring (principles and interlaboratory standardization), and response-related predictors of survival. Furthermore, updates are provided on the increasing prevalence of CML and its implications and on the changing cost of care for CML, taking into account the forthcoming impact of availability of generic imatinib. 

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book provides state-of-the-art reviews of key issues and recent developments relating to chronic myeloid leukemia (CML), acquainting the reader with advances in research, treatment, and promotion of public health. Among the management topics addressed are the choices, advantages, and pitfalls of first-, second-, and third-line treatments; the European LeukemiaNet recommendations; management of adverse effects of tyrosine kinase inhibitors (TKI); management of CML blast crisis; management of pregnancy in the context of CML; the role of hematopoietic cell transplantation; the current experience with TKI discontinuation; and the value of interferon α in improving the outcome of TKI treatment. Various aspects of relevance to treatment outcome are discussed, including prognostic scores, molecular monitoring (principles and interlaboratory standardization), and response-related predictors of survival. Furthermore, updates are provided on the increasing prevalence of CML and its implications and on the changing cost of care for CML, taking into account the forthcoming impact of availability of generic imatinib. 

More books from Springer International Publishing

Cover of the book Towards a Rational Legislative Evaluation in Criminal Law by
Cover of the book Social Network Analysis in Predictive Policing by
Cover of the book High Calorie Diet and the Human Brain by
Cover of the book The Thinking University by
Cover of the book Towards Sustainable Livelihoods and Ecosystems in Mountain Regions by
Cover of the book Computations and Computing Devices in Mathematics Education Before the Advent of Electronic Calculators by
Cover of the book Theory and Applications of Non-integer Order Systems by
Cover of the book Prokaryotic Systems Biology by
Cover of the book The Visual Neuroscience of Robotic Grasping by
Cover of the book Advances in Design for Inclusion by
Cover of the book Nevanlinna Theory, Normal Families, and Algebraic Differential Equations by
Cover of the book Social Networks and Surveillance for Society by
Cover of the book The History of Business in Africa by
Cover of the book Media and Metamedia Management by
Cover of the book Transdisciplinary Professional Learning and Practice by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy